Skip to main content
Premium Trial:

Request an Annual Quote

Med BioGene, Duke Expand Lymphoma Dx Collaboration

NEW YORK (GenomeWeb News) – Med BioGene said today that it has expanded its lymphoma diagnostics collaboration with Duke University to include additional collaborators from Northwestern University, Indiana University, and the University of Hong Kong.
Vancouver, BC-based Med BioGene said the expansion of the collaboration was facilitated through Duke’s establishment of the Working Group in Hematologic Malignancies. The first project of the group is to develop genomic-based tests for lymphoma, including Med BioGene’s LymphExpress Dx.
Med BioGene and Duke formed their collaboration in March 2007 to develop and validate biomarkers for lymphoma and leukemia. Under that collaboration, Duke is providing samples for Med BioGene’s gene expression-profiling system.
Erinn Brishko, CEO of Med BioGene, said that the expanded alliance “provides a significant base of expertise in all required areas and patient samples for analysis.”

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.